GlassScriptPhysician profile
Jerry Kong
NPI 1023293909
$1,388.91
in general payments reported to CMS, 2019-2025
13 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $134 · 2023: $379 · 2024: $403 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Education: $85.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.49 |
| Education | $85.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $432.40 | 2021-2025 | Xtampza |
| Biotronik Nro, INC. | $384.54 | 2023-2025 | Prospera, Biotronik |
| Nevro Corp. | $134.17 | 2021-2023 | Senza |
| Teva Pharmaceuticals USA, INC. | $85.49 | 2023 | |
| Scilex Pharmaceuticals INC. | $70.70 | 2021-2023 | Ztlido |
| Pfizer INC. | $68.59 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $56.21 | 2022-2023 | Seglentis |
| Boston Scientific Corporation | $54.41 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $33.02 | 2022 | |
| Impel Pharmaceuticals LLC | $22.76 | 2025 | Trudhesa |
| Sanofi-Aventis U.S. LLC | $18.09 | 2023 | |
| Virtus Pharmaceuticals LLC | $14.67 | 2025 | Levorphanol Tartrate |
| Ucb, INC. | $13.86 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.